Stocks · Health care · Pharmaceutical Preparations

Axsome Therapeutics, Inc.

AXSM Clue Score54
United States Fiscal year ends December CIK 0001579428 Results filed 2 Nov 2026

What the insiders did Mostly scheduled

Insider
Date
Role
Action
Shares
Price
Amount
Mark Coleman
23 Feb 2026
Director
Exercised, kept
6,250
$4.95
$30.94K
Mark Coleman
20 Feb 2026
Director
Exercised, kept
12,485
$4.95
$61.80K
Mark Coleman
10 Feb 2026
Director
Exercised, kept
5,193
$8.02
$41.65K
Mark Coleman
3 Jan 2025
Director
Exercised, kept
9,127
$9.00
$82.14K
Mark Coleman
19 Nov 2024
Director
Exercised, kept
33,410
$5.94
$198.46K
Mark Coleman
3 Jan 2023
Director
Exercised, kept
17,501
$1.30
$22.75K
Mark Coleman
15 Mar 2022
Director
Exercised, kept
3,496
$1.30
$4.54K
Roger Jeffs
10 Jan 2020
Director
Exercised, kept
34,866
$12.95
$451.51K
Roger Jeffs
10 Jan 2020
Director
Exercised, kept
11,000
$4.95
$54.45K
Roger Jeffs
10 Jan 2020
Director
Exercised, kept
5,193
$8.02
$41.65K
Roger Jeffs
10 Jan 2020
Director
Exercised, kept
9,127
$9.00
$82.14K
Roger Jeffs
3 Jul 2019
Director
Exercised, kept
13,000
$3.45
$44.85K
Roger Jeffs
3 Jul 2019
Director
Exercised, kept
39,948
$2.85
$113.85K
Roger Jeffs
3 Jul 2019
Director
Exercised, kept
3,672
$3.67
$13.48K
Roger Jeffs
29 Mar 2017
Director
Exercised, kept
35,194
$4.95
$174.21K
Roger Jeffs
29 Mar 2017
Director
Exercised, kept
7,344
$3.67
$26.95K

What was left out

Form 4 filings counted 178
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 19
Sales straight out of an exercise 53
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 2,185,486
History held since 23 Nov 2015